| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/08/2004 | WO2004000884A3 Compositions and methods for apo-b48 and apo-b100 assay |
| 04/08/2004 | WO2003106684A3 A method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003103709A3 Cd200-receptor mediated modulation of bone development |
| 04/08/2004 | WO2003101387A3 Globulin protein to lower cholesterol in humans |
| 04/08/2004 | WO2003100428A3 Method for diagnosing a tumor in a patient by determining pibf |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003089000A3 Anti-hiv composition, production method thereof and medicament |
| 04/08/2004 | WO2003076947A3 Method for monitoring collagen type ii degradation in cartilage |
| 04/08/2004 | WO2003076610A3 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
| 04/08/2004 | WO2003076455A3 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003033646A8 Compositions and methods for the modulation of viral maturation |
| 04/08/2004 | WO2003017817A3 Diagnosis, prevention and treatment of cancer |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002091212A3 Modular personal device system |
| 04/08/2004 | WO2002086082A3 Isolation of neural stem cells using gangliosides and other surface markers |
| 04/08/2004 | WO2002083854A3 Antibodies to vla-1 |
| 04/08/2004 | US20040068100 Comprises protein complexes for diagnosis and treatment of cell proliferative disorders; cell targeting and antitumor agents |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067556 Growth differentiation factor-6 |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067544 Invention shows that shear-induced mechanical force enhances strength of receptor-specific interactions between adhesion molecules such as FimH and target cells, and this phenomenon is dependent on structural properties of adhesion molecules |
| 04/08/2004 | US20040067542 Determining the aetiology of carcinogenesis in a mammal; comparing with normal cell/tissue; detection by immunohistochemistry or blotting techniques; use in diagnosis of prostate, breast and skin cancer |
| 04/08/2004 | US20040067534 Diversifying parent target and neutralizing agent in vitro; mutagenesis, recombinant or combinatorial synthetic methods; use in treatment and prevention of bacterial/viral infections, cancer and allergies |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067517 Of given amino acid sequence; binds with antibodies to the causative agent; expressed by spirochetes of Borrelia burgdorferi |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067496 System for production and screening of monoclonal antibodies |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067238 Novel compounds |
| 04/08/2004 | US20040067234 Inhibition of expression of the IDH1 or IDH2 gene or neutralization of the expression products promotes cell death; diagnosis and prognosis; screening for compounds that modulate apoptosis through the human IDH polypeptide |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067231 Agents for ameliorating symtoms caused by joint diseases |
| 04/08/2004 | US20040066166 Motor control apparatus having current supply phase correction |
| 04/08/2004 | CA2832136A1 Optimized fc variants and methods for their generation |
| 04/08/2004 | CA2816149A1 Optimized fc variants and methods for their generation |
| 04/08/2004 | CA2540354A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 04/08/2004 | CA2502735A1 Targeted cd1d molecules |
| 04/08/2004 | CA2500384A1 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 04/08/2004 | CA2500250A1 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | CA2499924A1 Lfa-1 alpha subunit antibodies and methods of use |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499826A1 Cell separation compositions and methods |
| 04/08/2004 | CA2499816A1 Optimized fc variants and methods for their generation |
| 04/08/2004 | CA2498787A1 Antibody for adcc and inducing cytokine production |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2498383A1 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | CA2498058A1 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses |
| 04/08/2004 | CA2495612A1 Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | CA2485970A1 Methods for diagnosing htlv-i-mediated diseases |
| 04/07/2004 | EP1405923A2 Gene mapping method using microsatellite genetic polymorphism markers |
| 04/07/2004 | EP1405914A1 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from flavobacterium heparinum |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1405077A2 Carcinoma-related peptides |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404865A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404816A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 04/07/2004 | EP1404813A2 Methods of culturing animal cells and polypeptide production in animal cells |
| 04/07/2004 | EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404710A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 04/07/2004 | EP1404706A2 Mycobacterial antigens expressed during latency |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404428A1 Methods for purifying highly anionic proteins |
| 04/07/2004 | EP1404367A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 04/07/2004 | EP1404366A2 Combination therapy of gamma-interferon and b cell specific antibodies |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404307A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 04/07/2004 | EP1399180A4 Sulfated ccr5 peptides for hiv-1 infection |
| 04/07/2004 | EP1363931A4 Methods to generate and identify monoclonal antibodies to a large number of human antigens |
| 04/07/2004 | EP1226433B1 Method for identifying active anti-apoptosis compounds |
| 04/07/2004 | EP0979277B1 Novel human tumour suppressor gene |
| 04/07/2004 | EP0889905B1 Cytokine antagonists and agonists |
| 04/07/2004 | EP0888543A4 Azatide peptidomimetics |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0712312B1 Suppression of inhibitors |
| 04/07/2004 | CN1487996A Transgenic transchromosomal rodents for making human antibodies |
| 04/07/2004 | CN1487953A Recepter in the EDb Fibronection domain |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1486990A Humanized gene engineering antibody resisting hepatitis E virus |
| 04/07/2004 | CN1144817C Novel human 'beta' 2 integrin 'alpha' sub unit |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |
| 04/06/2004 | US6716966 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 04/06/2004 | US6716965 Adipocyte complement related protein zacrp13 |
| 04/06/2004 | US6716606 For use in hematopoietic therapy; for arresting proliferation of leukemic cells |
| 04/06/2004 | US6716600 Persephin and related growth factors |